Merck & (MRK) Revenue — Quarter Ended Jun 30, 2023
Revenue for the reported quarter increased compared to both the immediately preceding quarter and the same quarter one year earlier. The company's top line showed sequential and year-over-year growth.
Key takeaway
Quarter ended Jun 30, 2023 · FY2023 Q2
Revenue for the reported quarter increased compared to both the immediately preceding quarter and the same quarter one year earlier. The company's top line showed sequential and year-over-year growth.
Financial snapshot
Reported revenue, sequential change, year-over-year change, and trailing four-quarter revenue.
Quarter revenue
$15B
Revenue reported for this quarter.
Quarter-over-quarter
+3.8%
Change from the immediately preceding quarter.
Year-over-year
+3.0%
Change from the comparable year-ago quarter.
Trailing four quarters
$58.3B
Sum of the latest four reported quarters.
Quarterly revenue trend
The latest four reported quarters with year-over-year comparisons.
| Period ended | Revenue | Year-over-year change |
|---|---|---|
| Sep 30, 2022 | $15B | +13.7% |
| Dec 31, 2022 | $13.8B | +2.3% |
| Mar 31, 2023 | $14.5B | -8.9% |
| Jun 30, 2023 | $15B | +3.0% |
Revenue performance
Revenue rose from the prior quarter, continuing an upward trend after a decline in the earlier quarter. Compared to the same period last year, revenue also improved.
Quarterly comparison
Sequentially, revenue increased from the preceding quarter. On an annual basis, revenue was higher than the same quarter a year ago.
What to watch
The company's operating cash flow for the first half of the year was significantly lower than the prior year, partly due to reduced sales of a key product.